Hu Y - Search Results

1

Heterogeneity of CD8⁺ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies.

Obeid JM, Wages NA, Hu Y, Deacon DH, Slingluff CL Jr. Obeid JM, et al. Among authors: hu y. Cancer Immunol Immunother. 2017 Jan;66(1):33-43. doi: 10.1007/s00262-016-1908-4. Epub 2016 Oct 21. Cancer Immunol Immunother. 2017. PMID: 27770170 Free PMC article.

2

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.

Hu Y, Petroni GR, Olson WC, Czarkowski A, Smolkin ME, Grosh WW, Chianese-Bullock KA, Slingluff CL Jr. Hu Y, et al. Cancer Immunol Immunother. 2014 Aug;63(8):779-86. doi: 10.1007/s00262-014-1551-x. Epub 2014 Apr 23. Cancer Immunol Immunother. 2014. PMID: 24756419 Free PMC article.

3

Inflammatory adverse events are associated with disease-free survival after vaccine therapy among patients with melanoma.

Hu Y, Smolkin ME, White EJ, Petroni GR, Neese PY, Slingluff CL Jr. Hu Y, et al. Ann Surg Oncol. 2014 Nov;21(12):3978-84. doi: 10.1245/s10434-014-3794-3. Epub 2014 May 20. Ann Surg Oncol. 2014. PMID: 24841355 Free PMC article.

4

Utility of sentinel lymph node biopsy for solitary dermal melanomas.

Hu Y, Shah P, Stukenborg GJ, Slingluff CL Jr. Hu Y, et al. J Surg Oncol. 2015 Jun;111(7):800-7. doi: 10.1002/jso.23890. Epub 2015 Feb 24. J Surg Oncol. 2015. PMID: 25712273 Free PMC article.

5

Localization of the Sentinel Lymph Node in Melanoma Without Blue Dye.

Hu Y, Melmer PD, Slingluff CL Jr. Hu Y, et al. Ann Surg. 2016 Mar;263(3):588-92. doi: 10.1097/SLA.0000000000001187. Ann Surg. 2016. PMID: 25775064 Free PMC article.

6

Recent trends in National Institutes of Health funding for surgery: 2003 to 2013.

Hu Y, Edwards BL, Brooks KD, Newhook TE, Slingluff CL Jr. Hu Y, et al. Am J Surg. 2015 Jun;209(6):1083-9. doi: 10.1016/j.amjsurg.2015.01.015. Epub 2015 Mar 21. Am J Surg. 2015. PMID: 25929766 Free PMC article. Review.

7

Long-term outcomes of helper peptide vaccination for metastatic melanoma.

Hu Y, Kim H, Blackwell CM, Slingluff CL Jr. Hu Y, et al. Ann Surg. 2015 Sep;262(3):456-64; discussion 462-4. doi: 10.1097/SLA.0000000000001419. Ann Surg. 2015. PMID: 26258314 Free PMC article. Clinical Trial.

8

Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges.

Obeid J, Hu Y, Slingluff CL Jr. Obeid J, et al. Among authors: hu y. Semin Oncol. 2015 Aug;42(4):549-61. doi: 10.1053/j.seminoncol.2015.05.006. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320060 Free PMC article. Review.

9

Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experience.

Ramirez AG, Wages NA, Hu Y, Smolkin ME, Slingluff CL Jr. Ramirez AG, et al. Among authors: hu y. Cancer Immunol Immunother. 2015 Dec;64(12):1531-9. doi: 10.1007/s00262-015-1758-5. Epub 2015 Sep 21. Cancer Immunol Immunother. 2015. PMID: 26392296 Free PMC article. Clinical Trial.

10

The heterogeneity of tumor-infiltrating CD8+ T cells in metastatic melanoma distorts their quantification: how to manage heterogeneity?

Obeid JM, Hu Y, Erdag G, Leick KM, Slingluff CL Jr. Obeid JM, et al. Among authors: hu y. Melanoma Res. 2017 Jun;27(3):211-217. doi: 10.1097/CMR.0000000000000330. Melanoma Res. 2017. PMID: 28118270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,882 results

Search Page

Filters